British Pharmacopoeia 2020
- The British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency (MHRA)
- TSO (The Stationery Office)
New, legally enforced standards, available from 1 August 2019. All Europoean Pharmacopoeial texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2020
The BP 2020 supersedes the BP 2019 and becomes legally effective on 1 January 2020. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
35 new BP monographs, 40 new Ph. Eur. monographs
331 amended BP monographs
Five new monographs for unlicensed formulations, two new monographs for herbal medicines
One new and one amended BP Veterinary monographs
All monographs from the Ph. Eur. 9th Edition including Supplements 9.1 to 9.8
Three in-year online and offline download product updates to integrate the Ph. Eur. Supplements 10.0, 10.1 and 10.2
Single named user download for offline use. No print copy or online access.
(£1,050.00 inc. VAT)
|Format||Download||Published||30 Jul 2019|
|Availability||Not yet published: available to order||Delivery||Delivery options and charges|